Category Archives: CybAero

CybAero in the clear?

Facebooktwittergoogle_pluslinkedinmailFacebooktwittergoogle_pluslinkedinmail

Shortly before Easter CybAero announced a financing agreement with a London-based company, Alpha Blue Ocean. This agreement gives CybAero access to (up to) 52.5 MSEK in 13 convertible loans. The day after, March 29th finally came the postponed year-end report, showing a loss of 155 MSEK after tax. I still wonder if this Easter 2018 was an (crash-) landing site for CybAero – or a take-off point. Continue reading

CybAero

CybAero and Dignitana – short update

Facebooktwittergoogle_pluslinkedinmailFacebooktwittergoogle_pluslinkedinmail

Yesterday I wrote a post in the current situation in CybAero. Here is a short update on CybAero and Dignitana. CybAero first: During June a number of question marks regarding the company needs straightening out. Today a press release announcing a new CEO was issued. This seems like a natural step after a new strategic partner was brought in in December, an new chairman was elected in February and the latest remarks made by the auditors on the 2015 Annual Report, placing the share at the NASDAQ surveillance list. Continue reading

CybAero in a crisis

Facebooktwittergoogle_pluslinkedinmailFacebooktwittergoogle_pluslinkedinmail

Investors in CybAero have recently have had their patience tested. Mine passed the test but judged from the development in share price, not all did. Nevertheless the two first weeks of May have put CybAero back on the map – and made the share price jump up and down. The past weeks have made it clear that CybAero is in a crisis, and things are running tight for the company in more ways. Continue reading

Portfolio performance March 2016

Portfolio performance March

Facebooktwittergoogle_pluslinkedinmailFacebooktwittergoogle_pluslinkedinmail

March have been a month of extremes in the portfolio. Overall, the portfolio performance is up by 5% on average, but in one end, Fortnox went up 45% and Nexam 40 %, while on the other hand Dignitana went down 13.5 % and G5 Entertainment 11%. In all, the portfolio has not yet recovered from the onslaught in January and February and is still down 15 %, while the broad OMX-SPI is down 4.3 %. Continue reading

Short news

Short news shortly before Easter

Facebooktwittergoogle_pluslinkedinmailFacebooktwittergoogle_pluslinkedinmail

This week’s main news from my portfolio concerns Fortnox. But besides this a number of things are happening. In this short news post I will visit Recyctec, Nexam, Heliospectra, cast an eye on a noteworthy share price development concerning CybAero, and finally I give links to three resent investor meetings.

The main news this week was of course the takeover bid on Fortnox Monday 14th. Norwegian Visma made an offer of +32%, the general meeting was postponed until May, and investors are right now waiting for more information on the bid. During the week rumours of competing bids – nice if the price is up! – resistance from the main owner, pros and cons, etc. was a topic in different forums. And again I wonder: for many of the participants in these debates it seems more like football fans discussing their favourite team, than investors trying to figure out how they make the best investment. Continue reading

Portfolio performance February 2016

Portfolio performance February 2016

Facebooktwittergoogle_pluslinkedinmailFacebooktwittergoogle_pluslinkedinmail

It seems as if February is the month, where I have to adjust to two-digit losses – calculated in percent. Overall, the portfolio performance of February is miserable. On average 10 % down, while OMXSPI is up 2 %. 5 out of 14 shares are two-digits down ranging from 15 to 34 %. Only two shares are up, Dignitana 3.7 % and Heliospectra 6.9 – the two of them is 36 % of my portfolio. Dignitana is by far my largest position, and this fact compensates me partly for the general downfall.

On a scale from ‘awful’ to ‘heavy loss’ comes Photocat (-34 %), Recyctec (-30 %), IVISYS (-24 %), Nexam Chemical (-18 %), and Cantargia (-16 %). Continue reading

End of report season

Facebooktwittergoogle_pluslinkedinmailFacebooktwittergoogle_pluslinkedinmail

It is the end of report season. Two months after New Year the report season goes towards the end. Companies listed on the different share markets must report within two months and for small companies with only a few employees the report often comes close to the last minute – in this case the last two weeks of February. Some companies choose to close their books on another date than New Year and of course, their reports turn up differently.

The only company in my growth share portfolio not following the calendar rhythm is Phase Holographic, who reports Q3 on March 30th.

A week ago, I posted an update on A1M Pharma, IVISYS, Nexam Chemical, and AroCell – and prior on Fortnox. This week it is Photocat, G5 Entertainment, Dignitana, Recyctec, CybAero, and Heliospectra. This week there is just one winner: Heliospectra. For Recyctec and CybAero Friday was blood red after the reports. Let’s take them one at a time: Continue reading

Portfolio performance

Portfolio performance January 2016

Facebooktwittergoogle_pluslinkedinmailFacebooktwittergoogle_pluslinkedinmail

During January, I have on two occasions dealt with the share price development. The month have been really volatile with huge shifts in share price changing one winner one week to a looser the next. During the first half of the month the portfolio performance was above average, but in the latter below.

In this month, one share has lost a third of its value, two shares a quarter of the value and one a fifth. On an equal weight basis, the portfolio is down 9.6 % – compared to the 7.1 % of the broad Stockholm index (SPI). Continue reading

Year-end reports

Year-end reports

Facebooktwittergoogle_pluslinkedinmailFacebooktwittergoogle_pluslinkedinmail

February is the months for year-end reports. The year circle of many companies follows the calendar, and throughout February, they are published – with a few in January and a few in March.

For growth shares at an early stage of their development the year-end reports is not the main driver of the share price. For lager companies guidance given in reports often have an impact on the share price. The share price development of growth shares are governed more by non-financial press releases: a CE-marking, an initial order, a FDA-approval etc. than by financial results.

Of my portfolio, I expect the share price of Nexam will gain by the report – with Fortnox, G5 Entertainment, Heliospectra, and Recyctec as probable benefactors. Continue reading

The effect of minor crisis

The effect of crisis

Facebooktwittergoogle_pluslinkedinmailFacebooktwittergoogle_pluslinkedinmail

I have often wondered how hard crises on the share market hits my growth share portfolio. Consequently, in this post I will take a closer look of the effect of the development on the share market the first week of 2016. The agenda was set by a new crisis in the Middle East (Saudi Arabia vs. Iran) and heavy downfalls on the Chinese share market affecting markets all over the world. Dow Jones is down 6%, FTSE 100 is down 5 % and in Copenhagen, the broad index OMXCPI is down 4 % and in Stockholm OMXSPI is down almost 7 %.

The Swedish share market was closed Tuesday afternoon and Wednesday. In effect, this week only contains 3½ trading days. The feeling I had Friday afternoon (without firmly checking) was that it had been an expensive week – especially Thursday were grim. And that my losses exceeded the general downfall. Continue reading